Cargando…

Interleukin-1 blockade with RPH-104 in patients with acute ST-elevation myocardial infarction: study design and rationale

BACKGROUND: Myocardial injury of ST-segment elevation myocardial infarction (STEMI) initiates an intense inflammatory response that contributes to further damage and is a predictor of increased risk of death or heart failure (HF). Interleukin-1 (IL-1) is a key mediator of local and systemic inflamma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samsonov, M., Bogin, V., Van Tassell, B. W., Abbate, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074403/ https://www.ncbi.nlm.nih.gov/pubmed/33902621 http://dx.doi.org/10.1186/s12967-021-02828-z

Ejemplares similares

Effect of interleukin-1 blockade with anakinra on leukocyte count in patients with ST-segment elevation acute myocardial infarction
por: Del Buono, Marco Giuseppe, et al.
Publicado: (2022)

Interleukin-1 Blockade in Acute Myocardial Infarction and Heart Failure: Getting Closer and Closer
por: Toldo, Stefano, et al.
Publicado: (2017)

Interleukin‐1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST‐Segment–Elevation Myocardial Infarction
por: Abbate, Antonio, et al.
Publicado: (2020)

The Midwest ST-Elevation Myocardial Infarction Consortium: Design and Rationale
por: Yildiz, Mehmet, et al.
Publicado: (2021)

SYSTEMI - systemic organ communication in STEMI: design and rationale of a cohort study of patients with ST-segment elevation myocardial infarction
por: Bönner, Florian, et al.
Publicado: (2023)

Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)
por: Anstensrud, Anne Kristine, et al.
Publicado: (2019)

Ultrasound enhanced prehospital thrombolysis using microbubbles infusion in patients with acute ST elevation myocardial infarction: Rationale and design of the Sonolysis study
por: Slikkerveer, Jeroen, et al.
Publicado: (2008)

Rationale and design of the Henan ST elevation myocardial infarction (STEMI) registry: a regional STEMI project in predominantly rural central China
por: Zhang, You, et al.
Publicado: (2019)

Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study
por: Van Tassell, Benjamin, et al.
Publicado: (2022)

Sonothrombolysis in the ambulance for ST-elevation myocardial infarction: rationale and protocol
por: El Kadi, S., et al.
Publicado: (2020)

Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration
por: Gu, Youlan L, et al.
Publicado: (2009)

Rationale and design of a prospective, observational study for the QUantitative EStimation of Thrombus burden in patients with ST-Elevation Myocardial Infarction using micro-computed tomography: the QUEST-STEMI trial
por: Karagiannidis, Efstratios, et al.
Publicado: (2020)

Metformin in non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial
por: Lexis, Chris P. H., et al.
Publicado: (2012)

Design and rationale of the North Indian ST‐Segment Elevation Myocardial Infarction Registry: A prospective cohort study
por: Arora, Sameer, et al.
Publicado: (2019)

North American COVID-19 ST-Segment-Elevation Myocardial Infarction (NACMI) registry: Rationale, design, and implications
por: Dehghani, Payam, et al.
Publicado: (2020)

Affinity Capture Elution (ACE) ELISA Method Development and Validation for Novel RPH-104 Drug Immunogenicity Evaluation
por: Kolganova, Maria A., et al.
Publicado: (2022)

The Rationale of Neprilysin Inhibition in Prevention of Myocardial Ischemia-Reperfusion Injury during ST-Elevation Myocardial Infarction
por: Bellis, Alessandro, et al.
Publicado: (2020)

Interleukin-1 blockade in cardiac sarcoidosis: study design of the multimodality assessment of granulomas in cardiac sarcoidosis: Anakinra Randomized Trial (MAGiC-ART)
por: Kron, Jordana, et al.
Publicado: (2021)

Rationale and design of a prospective multi-center randomized trial of EARLY treatment by rivaroxaban versus warfarin in ST-segment elevation MYOcardial infarction with Left Ventricular Thrombus (EARLY-MYO-LVT trial)
por: He, Jie, et al.
Publicado: (2020)

Effects of nicorandil on myocardial infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: study design and protocol for the randomized controlled trial
por: JIANG, Xiao-Si, et al.
Publicado: (2020)

Prognostic Implications of Clinical, Laboratory and Echocardiographic Biomarkers in Patients with Acute Myocardial Infarction—Rationale and Design of the ‘‘CLEAR-AMI Study’’
por: Daios, Stylianos, et al.
Publicado: (2023)

Protocol: does sodium nitrite administration reduce ischaemia-reperfusion injury in patients presenting with acute ST segment elevation myocardial infarction? Nitrites in acute myocardial infarction (NIAMI)
por: Siddiqi, Nishat, et al.
Publicado: (2013)

Alterations in the Interleukin-1/Interleukin-1 Receptor Antagonist Balance Modulate Cardiac Remodeling following Myocardial Infarction in the Mouse
por: Abbate, Antonio, et al.
Publicado: (2011)

Tombstoning ST-Elevation Myocardial Infarction
por: Balci, Bahattin
Publicado: (2009)

ST Elevation Myocardial Infarction in the elderly
por: Franken, Marcelo, et al.
Publicado: (2012)

Mistaken ST-Elevation Myocardial Infarction
por: Wolk, Brian J.
Publicado: (2015)

Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease
por: Franczyk-Skóra, Beata, et al.
Publicado: (2013)

Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI)
por: Chorell, Elin, et al.
Publicado: (2020)

Study protocol of the PEruvian Registry of ST-segment Elevation Myocardial Infarction II (PERSTEMI-II) study
por: Chacón-Díaz, Manuel, et al.
Publicado: (2021)

Clinical and epidemiological profile of ST‐segment elevation myocardial infarction patients in a megacity of west of Iran
por: Janjani, Parisa, et al.
Publicado: (2023)

Rationale and design of EXPLORE: a randomized, prospective, multicenter trial investigating the impact of recanalization of a chronic total occlusion on left ventricular function in patients after primary percutaneous coronary intervention for acute ST-elevation myocardial infarction
por: van der Schaaf, René J, et al.
Publicado: (2010)

Using Smart Technology to Improve Outcomes in Myocardial Infarction Patients: Rationale and Design of a Protocol for a Randomized Controlled Trial, The Box
por: Treskes, Roderick Willem, et al.
Publicado: (2017)

Phenotypic characterization of the Hordeum bulbosum derived leaf rust resistance genes Rph22 and Rph26 in barley
por: Yu, Xiaohui, et al.
Publicado: (2022)

Association of Interleukin 8 and Myocardial Recovery in Patients with ST-Elevation Myocardial Infarction Complicated by Acute Heart Failure
por: Husebye, Trygve, et al.
Publicado: (2014)

Plasma interleukin 6 levels are associated with cardiac function after ST-elevation myocardial infarction
por: Groot, Hilde E., et al.
Publicado: (2018)

Effect of Interleukin-17 in the Activation of Monocyte Subsets in Patients with ST-Segment Elevation Myocardial Infarction
por: Garza-Reyes, Montserrat Guadalupe, et al.
Publicado: (2020)

Mineralocorticoid Receptor Antagonist Pretreatment to MINIMISE Reperfusion Injury After ST‐Elevation Myocardial Infarction (The MINIMISE STEMI Trial): Rationale and Study Design
por: Bulluck, Heerajnarain, et al.
Publicado: (2015)

Mobile application to optimize care for ST-segment elevation myocardial infarction patients in a large healthcare system, STEMIcathAID: rationale and design
por: Krishnamoorthy, Parasuram, et al.
Publicado: (2021)

Rationale and design of the CAPAMIS study: Effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke
por: Vila-Corcoles, Angel, et al.
Publicado: (2010)

Thyrotoxicosis Mimicking ST Elevation Myocardial Infarction
por: Rymer De Marchena, Ingrid, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_99c6a830lubdv9imvl03mqp44t